sudeep pharma ipo allotment status

 Sudeep Pharma IPO Allotment Status — Latest Update & Full Details

The highly anticipated Sudeep Pharma IPO has reached the very vital allotment date, and now every investor is excited to know whether they have secured shares or not. Basically, there was huge hype for this IPO in the market due to robust demand from all investor segments. Now, as the finalization of the allotment begins, thousands of applicants are checking their status online to confirm the outcome of their investment. This article describes the complete process, important timelines, subscription details, and what happens next for investors.

Sudeep Pharma IPO Timeline

The subscription window for the Sudeep Pharma IPO opened on November 21, 2025, and closed on November 25, 2025. The basis of allotment is scheduled to be finalized on November 26, 2025. For applicants who are not allotted shares, refund or fund unblocking will begin on November 27, 2025, while the same day the allotted shares will be credited into the respective Demat accounts. The stock is expected to be listed on the BSE and NSE on November 28, 2025. These dates are critical for investors tracking allotment status and listing day performance.

Subscription Status and Market Demand

The IPO saw an unprecedented response and became heavily oversubscribed. The QIB category saw an astonishing subscription of about 213 times, showing immense institutional confidence in the firm. Similarly, the HNI/NII category showed an approximate subscription of about 117 times, reflecting high interest among wealthy investors. Retail subscription also followed with a lot of enthusiasm at about 16 times, and the overall subscription reached about 94 times. A lot draw will strictly be the basis of allotment for retail investors due to such heavy oversubscription.

How to Check Sudeep Pharma IPO Allotment Status

Investors can check the allotment status through various mediums. First, one can visit the website of an IPO registrar, then select "Sudeep Pharma IPO" from the company list and enter PAN, application number, or Demat/DP ID to check the result. Second, it can also be checked through the website of a stock exchange, which is usually either the NSE or BSE, by selecting the IPO name and entering PAN or application information. And lastly, applicants who have applied via broker apps like Zerodha, Upstox, Groww, Angel One, ICICI Direct, or any other platform can easily see the IPO section in the app where the status would be updated automatically once confirmed.

Grey Market Premium and Listing Expectations

The grey market premium for Sudeep Pharma is presently trading in the range of ₹85 to ₹95 above the issue price. With the IPO issue price at ₹593 per share, market expectations indicate its potential listing price at ₹675 to ₹688. This shows positive sentiment and the likelihood of listing gains for those who get allotment. However, one must not forget that GMP is only an informal indicator, and it does not guarantee the final listing performance, as actual price movement depends on the broader market conditions and investor behavior.

What Happens After Allotment

The shares will be credited to the Demat accounts of applicants who get the allotment by November 27, 2025, and trading will be possible once the stock lists on November 28, 2025. Applicants not getting allotment need not take any action; their blocked funds will automatically be released or refunded to their bank account used during the ASBA application. Investors should also be prepared for possible volatility on listing day, since high oversubscription often results in rapid price fluctuations as traders seek listing gains.

Conclusion Surprisingly, the Sudeep Pharma IPO has drawn massive investor attention with impressive subscription numbers and strong market expectations. Due to excessive demand, the allotment chances for retail investors will be low, and only those who receive shares may get some benefit out of early listing gains. Even investors who do not get an allotment will learn a lesson from this and will continue to track upcoming IPOs. Overall, the Sudeep Pharma IPO reflects the strong momentum and rising investor confidence in the pharmaceutical and specialty chemical sector.